UNIVERSITY OF MISSISSIPPI MEDICAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $15M
- Transactions
- 3,533
- Companies
- 40
- Average per transaction
- $4,244
Who reported the payments
| Merck | $1,088,645 |
| Pfizer | $1,019,055 |
| AstraZeneca | $664,251 |
| United Therapeutics Corporation | $664,014 |
| AbbVie | $615,297 |
| Gilead | $586,399 |
| Incyte Corporation | $557,895 |
| Takeda Pharmaceuticals U.S.A., Inc. | $554,852 |
| Janssen Research & Development, LLC | $513,155 |
| Intuitive Surgical | $504,685 |
| Med-el Corporation | $466,170 |
| E.r. Squibb & Sons, L.L.C. | $431,678 |
| Jazz Pharmaceuticals Inc. | $426,939 |
| Depuy Synthes Products, Inc. | $414,949 |
| CSL Behring | $395,040 |
| Vertex | $294,624 |
| Novartis | $277,297 |
| Livanova USA, Inc. | $251,461 |
| Shire North American Group Inc | $240,410 |
| Medical Device Business Services, Inc. | $217,946 |
| Boehringer Ingelheim | $200,004 |
| W. L. Gore & Associates, Inc. | $179,970 |
| Galvanize Therapeutics, Inc | $170,482 |
| Stryker | $162,748 |
| Boston Scientific | $160,417 |
| Regeneron | $156,480 |
| Orthopediatrics Corp. | $142,901 |
| Synthes GmbH | $130,000 |
| Kls-martin L.p. | $128,277 |
| Bayer | $123,034 |
| Cvrx, Inc. | $117,291 |
| Medtronic | $112,795 |
| GE HealthCare | $112,743 |
| Inari Medical, Inc. | $109,922 |
| Novo Nordisk AS | $107,406 |
| GSK | $101,444 |
| Alkermes, Inc. | $99,961 |
| Genentech, Inc. | $85,143 |
| Intercept Pharmaceuticals, Inc. | $79,210 |
| Eli Lilly | $78,619 |